Article Information
History
- December 21, 2021.
Article Versions
- You are currently viewing Version 1 of this article (December 21, 2021 - 11:31).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Shabir A. Madhi, Ph.D.1,2,*,
- Gaurav Kwatra, Ph.D.1,2,
- Jonathan E. Myers, M.D.3,
- Waasila Jassat, M.Med.4,
- Nisha Dhar, Ph.D.1,
- Christian K. Mukendi, M.Sc.1,
- Amit J. Nana, B.Sc.1,
- Lucille Blumberg, M.Med.4,
- Richard Welch, B.Sc.4,
- Nicoletta Ngorima-Mabhena, M.B.Ch.B.5 and
- Portia C. Mutevedzi, Ph.D.1
- 1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 2African Leadership in Vaccinology Expertise, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 3Centre for Environmental and Occupational Health Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
- 4National Institute for Communicable Diseases, Johannesburg, South Africa
- 5ResearchLinkMe, Johannesburg, South Africa
- ↵*Corresponding author:
Shabir A. Madhi, University of the Witwatersrand, Phillip Tobias Bldg., Princess of Wales St., Parktown, 2193, Gauteng, South Africa. Cell: +27 (82) 8706672. Email: shabir.madhi@wits{at}ac.za
Posted December 21, 2021.
